Gregory Conn
CIK: 0001770008
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PDS Biotechnology Corp
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 12, 2026PDSB
PDS Biotechnology Corp
Award(A)DirectEmployee Stock Option (Right to Buy)
150K shares- - Jun 12, 2025PDSB
PDS Biotechnology Corp
Award(A)DirectEmployee Stock Option (Right to Buy)
40K shares- - Feb 28, 2024PDSB
PDS Biotechnology Corp
Award(A)DirectEmployee Stock Option (Right to Buy)
46.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 12, 2026 | PDSB PDS Biotechnology Corp | Award(A) Employee Stock Option (Right to Buy) | 150,000 | - | - | Direct |
| Jun 12, 2025 | PDSB PDS Biotechnology Corp | Award(A) Employee Stock Option (Right to Buy) | 40,000 | - | - | Direct |
| Feb 28, 2024 | PDSB PDS Biotechnology Corp | Award(A) Employee Stock Option (Right to Buy) | 46,648 | - | - | Direct |
1-3 of 3 transactions
About CONN GREGORY
CONN GREGORY (SEC CIK 0001770008) files insider reports with the SEC as Chief Scientific Officer of PDS Biotechnology Corp (PDSB).
Signal8 holds 2 ownership filings by CONN GREGORY, all Form 4s, filed between Jul 25, 2025 and Mar 3, 2026. Those filings report 3 transactions, from Feb 28, 2024 to Jan 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on CONN GREGORY's filings is in PRINCETON, NJ.
Recent filings by CONN GREGORY
Other insiders filing for PDS Biotechnology Corp (PDSB)
- Dawson John Andrew, Director
- Ramsdell Deborah, Director
- Wendel Bruce, Director
- SOON-SHIONG PATRICK, Director
- Banaag Arnold James, Director
- Trochimiuk Janetta, Principal Accounting Officer